DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity

Abstract

SARS-CoV-2 has caused a global pandemic, and has taken over 1.7 million lives as of mid-December, 2020. Although great progress has been made in the development of effective countermeasures, with several pharmaceutical companies approved or poised to deliver vaccines to market, there is still an unmet need of essential antiviral drugs with therapeutic impact for the treatment of moderate-to-severe COVID-19. Towards this goal, a high-throughput assay was used to screen SARS-CoV-2 nsp15 uracil-dependent endonuclease (endoU) function against 13 thousand compounds from drug and lead repurposing compound libraries. While over 80% of initial hit compounds were pan-assay inhibitory compounds, three hits were confirmed as nsp15 endoU inhibitors in the 1–20 μM range in vitro. Furthermore, Exebryl-1, a ß-amyloid anti-aggregation molecule for Alzheimer’s therapy, was shown to have antiviral activity between 10 to 66 μM, in Vero 76, Caco-2, and Calu-3 cells. Although the inhibitory concentrations determined for Exebryl-1 exceed those recommended for therapeutic intervention, our findings show great promise for further optimization of Exebryl-1 as an nsp15 endoU inhibitor and as a SARS-CoV-2 antiviral.

Authors:
; ; ; ; ORCiD logo; ; ; ; ; ; ORCiD logo; ; ; ; ; ; ; ; ORCiD logo;
Publication Date:
Research Org.:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH)
OSTI Identifier:
1779341
Alternate Identifier(s):
OSTI ID: 1806308
Report Number(s):
PNNL-SA-159108
Journal ID: ISSN 1932-6203; 10.1371/journal.pone.0250019
Grant/Contract Number:  
AC05-76RL01830; HHSN272201700059C; 75N93019D00021
Resource Type:
Published Article
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Name: PLoS ONE Journal Volume: 16 Journal Issue: 4; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science (PLoS)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; structural biology; structure-based drug discovery; COVID-19; native mass spectrometry; molecular modeling and simulation

Citation Formats

Choi, Ryan, Zhou, Mowei, Shek, Roger, Wilson, Jesse W., Tillery, Logan, Craig, Justin K., Salukhe, Indraneel A., Hickson, Sarah E., Kumar, Neeraj, James, Rhema M., Buchko, Garry W., Wu, Ruilian, Huff, Sydney, Nguyen, Tu-Trinh, Hurst, Brett L., Cherry, Sara, Barrett, Lynn K., Hyde, Jennifer L., Van Voorhis, Wesley C., and Wlodawer, ed., Alexander. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity. United States: N. p., 2021. Web. doi:10.1371/journal.pone.0250019.
Choi, Ryan, Zhou, Mowei, Shek, Roger, Wilson, Jesse W., Tillery, Logan, Craig, Justin K., Salukhe, Indraneel A., Hickson, Sarah E., Kumar, Neeraj, James, Rhema M., Buchko, Garry W., Wu, Ruilian, Huff, Sydney, Nguyen, Tu-Trinh, Hurst, Brett L., Cherry, Sara, Barrett, Lynn K., Hyde, Jennifer L., Van Voorhis, Wesley C., & Wlodawer, ed., Alexander. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity. United States. https://doi.org/10.1371/journal.pone.0250019
Choi, Ryan, Zhou, Mowei, Shek, Roger, Wilson, Jesse W., Tillery, Logan, Craig, Justin K., Salukhe, Indraneel A., Hickson, Sarah E., Kumar, Neeraj, James, Rhema M., Buchko, Garry W., Wu, Ruilian, Huff, Sydney, Nguyen, Tu-Trinh, Hurst, Brett L., Cherry, Sara, Barrett, Lynn K., Hyde, Jennifer L., Van Voorhis, Wesley C., and Wlodawer, ed., Alexander. Thu . "High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity". United States. https://doi.org/10.1371/journal.pone.0250019.
@article{osti_1779341,
title = {High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity},
author = {Choi, Ryan and Zhou, Mowei and Shek, Roger and Wilson, Jesse W. and Tillery, Logan and Craig, Justin K. and Salukhe, Indraneel A. and Hickson, Sarah E. and Kumar, Neeraj and James, Rhema M. and Buchko, Garry W. and Wu, Ruilian and Huff, Sydney and Nguyen, Tu-Trinh and Hurst, Brett L. and Cherry, Sara and Barrett, Lynn K. and Hyde, Jennifer L. and Van Voorhis, Wesley C. and Wlodawer, ed., Alexander},
abstractNote = {SARS-CoV-2 has caused a global pandemic, and has taken over 1.7 million lives as of mid-December, 2020. Although great progress has been made in the development of effective countermeasures, with several pharmaceutical companies approved or poised to deliver vaccines to market, there is still an unmet need of essential antiviral drugs with therapeutic impact for the treatment of moderate-to-severe COVID-19. Towards this goal, a high-throughput assay was used to screen SARS-CoV-2 nsp15 uracil-dependent endonuclease (endoU) function against 13 thousand compounds from drug and lead repurposing compound libraries. While over 80% of initial hit compounds were pan-assay inhibitory compounds, three hits were confirmed as nsp15 endoU inhibitors in the 1–20 μM range in vitro. Furthermore, Exebryl-1, a ß-amyloid anti-aggregation molecule for Alzheimer’s therapy, was shown to have antiviral activity between 10 to 66 μM, in Vero 76, Caco-2, and Calu-3 cells. Although the inhibitory concentrations determined for Exebryl-1 exceed those recommended for therapeutic intervention, our findings show great promise for further optimization of Exebryl-1 as an nsp15 endoU inhibitor and as a SARS-CoV-2 antiviral.},
doi = {10.1371/journal.pone.0250019},
journal = {PLoS ONE},
number = 4,
volume = 16,
place = {United States},
year = {Thu Apr 22 00:00:00 EDT 2021},
month = {Thu Apr 22 00:00:00 EDT 2021}
}

Works referenced in this record:

Simple and Minimally Invasive SID Devices for Native Mass Spectrometry
journal, July 2020


Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage
journal, August 2003


Accurate calculation of the absolute free energy of binding for drug molecules
journal, January 2016

  • Aldeghi, Matteo; Heifetz, Alexander; Bodkin, Michael J.
  • Chemical Science, Vol. 7, Issue 1
  • DOI: 10.1039/C5SC02678D

Evasion of Type I Interferon by SARS-CoV-2
journal, October 2020


Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays**
journal, October 2020

  • El‐Baba, Tarick J.; Lutomski, Corinne A.; Kantsadi, Anastassia L.
  • Angewandte Chemie International Edition, Vol. 59, Issue 52
  • DOI: 10.1002/anie.202010316

Suppressing Posttranslational Gluconoylation of Heterologous Proteins by Metabolic Engineering of Escherichia coli
journal, December 2007

  • Aon, J. C.; Caimi, R. J.; Taylor, A. H.
  • Applied and Environmental Microbiology, Vol. 74, Issue 4
  • DOI: 10.1128/AEM.01790-07

Structural and Functional Analyses of the Severe Acute Respiratory Syndrome Coronavirus Endoribonuclease Nsp15
journal, November 2007

  • Bhardwaj, Kanchan; Palaninathan, Satheesh; Alcantara, Joanna Maria Ortiz
  • Journal of Biological Chemistry, Vol. 283, Issue 6
  • DOI: 10.1074/jbc.M708375200

Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration
journal, November 2017


Open Babel: An open chemical toolbox
journal, October 2011

  • O'Boyle, Noel M.; Banck, Michael; James, Craig A.
  • Journal of Cheminformatics, Vol. 3, Issue 1
  • DOI: 10.1186/1758-2946-3-33

Native mass spectrometry reveals the simultaneous binding of lipids and zinc to rhodopsin
journal, February 2021

  • Norris, Carolanne E.; Keener, James E.; Perera, Suchithranga M. D. C.
  • International Journal of Mass Spectrometry, Vol. 460
  • DOI: 10.1016/j.ijms.2020.116477

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results
journal, March 1993

  • Chang, A. Y.; Kim, K.; Glick, J.
  • JNCI Journal of the National Cancer Institute, Vol. 85, Issue 5
  • DOI: 10.1093/jnci/85.5.388

Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
journal, May 2017

  • Deng, Xufang; Hackbart, Matthew; Mettelman, Robert C.
  • Proceedings of the National Academy of Sciences, Vol. 114, Issue 21
  • DOI: 10.1073/pnas.1618310114

Effect of DMSO on Protein Structure and Interactions Assessed by Collision-Induced Dissociation and Unfolding
journal, August 2017


Structural and Biochemical Characterization of Endoribonuclease Nsp15 Encoded by Middle East Respiratory Syndrome Coronavirus
journal, August 2018

  • Zhang, Lianqi; Li, Lei; Yan, Liming
  • Journal of Virology, Vol. 92, Issue 22
  • DOI: 10.1128/JVI.00893-18

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
journal, October 2020

  • Ma, Chunlong; Hu, Yanmei; Townsend, Julia Alma
  • ACS Pharmacology & Translational Science, Vol. 3, Issue 6
  • DOI: 10.1021/acsptsci.0c00130

Protein production by auto-induction in high-density shaking cultures
journal, May 2005


Antibacterial drug leads targeting isoprenoid biosynthesis
journal, December 2012

  • Zhu, W.; Zhang, Y.; Sinko, W.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 1
  • DOI: 10.1073/pnas.1219899110

Application performance analysis and efficient execution on systems with multi-core CPUs, GPUs and MICs: a case study with microscopy image analysis
journal, July 2016

  • Teodoro, George; Kurc, Tahsin; Andrade, Guilherme
  • The International Journal of High Performance Computing Applications, Vol. 31, Issue 1
  • DOI: 10.1177/1094342015594519

Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV ‐2
journal, May 2020

  • Kim, Youngchang; Jedrzejczak, Robert; Maltseva, Natalia I.
  • Protein Science, Vol. 29, Issue 7
  • DOI: 10.1002/pro.3873

Fast, accurate, and reliable molecular docking with QuickVina 2
journal, February 2015


A new coronavirus associated with human respiratory disease in China
journal, February 2020


The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
journal, October 2018

  • Janes, Jeff; Young, Megan E.; Chen, Emily
  • Proceedings of the National Academy of Sciences, Vol. 115, Issue 42
  • DOI: 10.1073/pnas.1810137115

Surface-Induced Dissociation: An Effective Method for Characterization of Protein Quaternary Structure
journal, November 2018


New Antiviral Target Revealed by the Hexameric Structure of Mouse Hepatitis Virus Nonstructural Protein nsp15
journal, July 2006


A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
journal, April 1999


Analysis of the RNase H activity by fluorescence resonance energy transfer
journal, October 2000

  • Miyashiro, H.; Kimura, T.; Tomiyama, M.
  • Nucleic Acids Symposium Series, Vol. 44, Issue 1
  • DOI: 10.1093/nass/44.1.55

The structure of the endoribonuclease XendoU: From small nucleolar RNA processing to severe acute respiratory syndrome coronavirus replication
journal, August 2006

  • Renzi, F.; Caffarelli, E.; Laneve, P.
  • Proceedings of the National Academy of Sciences, Vol. 103, Issue 33
  • DOI: 10.1073/pnas.0602426103

Major genetic marker of nidoviruses encodes a replicative endoribonuclease
journal, August 2004

  • Ivanov, K. A.; Hertzig, T.; Rozanov, M.
  • Proceedings of the National Academy of Sciences, Vol. 101, Issue 34
  • DOI: 10.1073/pnas.0403127101

Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family
journal, August 2006

  • Ricagno, S.; Egloff, M. -P.; Ulferts, R.
  • Proceedings of the National Academy of Sciences, Vol. 103, Issue 32
  • DOI: 10.1073/pnas.0601708103

Immobilized metal-affinity chromatography protein-recovery screening is predictive of crystallographic structure success
journal, August 2011

  • Choi, Ryan; Kelley, Angela; Leibly, David
  • Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 67, Issue 9
  • DOI: 10.1107/S1744309111017374

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
journal, April 2020


Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
journal, March 2020

  • Hackbart, Matthew; Deng, Xufang; Baker, Susan C.
  • Proceedings of the National Academy of Sciences, Vol. 117, Issue 14
  • DOI: 10.1073/pnas.1921485117

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
journal, April 2020


The Severe Acute Respiratory Syndrome Coronavirus Nsp15 Protein Is an Endoribonuclease That Prefers Manganese as a Cofactor
journal, October 2004


Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L
journal, November 2020

  • Sacco, Michael Dominic; Ma, Chunlong; Lagarias, Panagiotis
  • Science Advances, Vol. 6, Issue 50
  • DOI: 10.1126/sciadv.abe0751

Bayesian Deconvolution of Mass and Ion Mobility Spectra: From Binary Interactions to Polydisperse Ensembles
journal, April 2015